FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 12.8 milligram and ibuprofen 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clopamide 5 milligram and pindolol 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzalkonium chloride 1 milligram/1 gram and dimeticone 220 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely captopril 25 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely alverine citrate 5 milligram/1 gram and Sterculia gum 620 milligram/1 gram conventional release oral granules Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely econazole nitrate 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dried aluminium hydroxide gel 120 milligram/1 milliliter and magnesium hydroxide 60 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mestranol 50 microgram and norethisterone 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine sulfate 15 milligram and theophylline 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 5 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely captopril 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 20 microgram and gestodene 75 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 10 milligram and dequalinium chloride 250 microgram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 750 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diclofenac sodium 75 milligram and misoprostol 200 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clioquinol 10 milligram/1 milliliter and flumetasone pivalate 200 microgram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 2 milligram and norethisterone acetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and losartan potassium 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely aluminium hydroxide 600 milligram and magnesium hydroxide 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely desogestrel 150 microgram and ethinylestradiol 20 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clopamide 5 milligram and pindolol 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely alverine citrate 5 milligram/1 gram and Sterculia gum 620 milligram/1 gram conventional release oral granules Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 60 milligram and paracetamol 1 gram/1 sachet effervescent powder for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cyclizine 30 milligram and dipipanone 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely domiphen bromide 500 microgram and lidocaine hydrochloride 5 milligram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/1 actuation conventional release nasal spray (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin (as amoxicillin sodium) 1 gram and clavulanic acid (as clavulanate potassium) 200 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lidocaine 70 milligram/1 gram and tetracaine 70 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely crotamiton 100 milligram/1 gram and hydrocortisone 2.5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 5 milligram and furosemide 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cod liver oil 114 milligram/1 gram and zinc oxide 380 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzthiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dorzolamide (as dorzolamide hydrochloride) 20 milligram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pseudoephedrine hydrochloride 60 milligram and triprolidine hydrochloride 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release transdermal cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ampicillin 250 milligram and flucloxacillin 250 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlordiazepoxide hydrochloride 5 milligram and clidinium bromide 2.5 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely caffeine 100 milligram and ergotamine tartrate 2 milligram/1 each conventional release rectal suppository Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amitriptyline 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram and urea 100 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzalkonium chloride 1 milligram/1 gram and dimeticone 220 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier

    Start Previous Page 30 of 35 Next End

    This concept is not in any reference sets

    Back to Start